Phase 2 Study of Oral K201 for Prevention of AF Recurrence (ARCTIC-AF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01067833
Recruitment Status : Terminated
First Posted : February 12, 2010
Last Update Posted : May 16, 2011
Information provided by:
Sequel Pharmaceuticals, Inc

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : October 2011
  Estimated Study Completion Date : December 2011